Significance of NPM1 Gene Mutations in AML

Significance of NPM1 Gene Mutations in AML

The aim of this literature review is to examine the significance of the nucleophosmin 1 (<i>NPM1</i>) gene in acute myeloid leukaemia (AML). This will include analysis of the structure and normal cellular function of NPM1, the type of mutations commonly witnessed in <i>NPM1</i&g...

Full description

Bibliographic Details
Main Authors:	Andrew Hindley, Mark Alexander Catherwood, Mary Frances McMullin, Ken I. Mills
Format:	Article
Language:	English
Published:	MDPI AG 2021-09-01
Series:	International Journal of Molecular Sciences
Subjects:	AML <i>NPM1</i> fragment analysis <i>FLT3</i> <i>DNMT3A</i>
Online Access:	https://www.mdpi.com/1422-0067/22/18/10040

Similar Items

The Impact of DNMT3A Status on NPM1 MRD Predictive Value and Survival in Elderly AML Patients Treated Intensively
by: Heiblig Maël, et al.
Published: (2021-04-01)

Modelling the Effects of MCM7 Variants, Somatic Mutations, and Clinical Features on Acute Myeloid Leukemia Susceptibility and Prognosis
by: Florin Tripon, et al.
Published: (2020-01-01)

Maturation State-Specific Alternative Splicing in <i>FLT3</i>-ITD and NPM1 Mutated AML
by: Anna Wojtuszkiewicz, et al.
Published: (2021-08-01)

Therapeutic Vulnerabilities in <i>FLT3</i>-Mutant AML Unmasked by Palbociclib
by: Iris Z. Uras, et al.
Published: (2018-12-01)

Study of HOTAIR LncRNA in AML patients in context to FLT3-ITD and NPM1 mutations status
by: Mona Salah, et al.
Published: (2021-06-01)

CD123 Is Consistently Expressed on <i>NPM1</i>-Mutated AML Cells
by: Vincenzo Maria Perriello, et al.
Published: (2021-01-01)

Bone Marrow Clonogenic Myeloid Progenitors from <i>NPM1</i>-Mutated AML Patients Do Not Harbor the <i>NPM1</i> Mutation: Implication for the Cell-Of-Origin of <i>NPM1+</i> AML
by: Rafael Diaz de la Guardia, et al.
Published: (2020-01-01)

Adverse Impact of DNA Methylation Regulatory Gene Mutations on the Prognosis of AML Patients in the 2017 ELN Favorable Risk Group, Particularly Those Defined by <i>NPM1</i> Mutation
by: James Yu, et al.
Published: (2021-05-01)

Simultaneous FLT3, NPM1 and DNMT3A mutations in adult patients with acute myeloid leukemia – case study
by: Tripon Florin, et al.
Published: (2019-07-01)

The Impact of <i>Flt3</i> Gene Mutations in Acute Promyelocytic Leukemia: A Meta-Analysis
by: Gledson L. Picharski, et al.
Published: (2019-09-01)

Acute myeloid leukemia patient with FLT3-ITD and NPM1 double mutation should undergo allogeneic hematopoietic stem cell transplantation in CR1 for better prognosis 
by: Huang Y, et al.
Published: (2019-05-01)

<i>TET2/IDH1/2/WT1</i> and <i>NPM1</i> Mutations Influence the <i>RUNX1</i> Expression Correlations in Acute Myeloid Leukemia
by: Sergiu Pasca, et al.
Published: (2020-11-01)

Evi1 abolishes the sensitivity of Flt3-ITD bearing acute myeloid leukemia stem cells to all-trans retinoic acid
by: Chi Huu Nguyen, et al.
Published: (2020-09-01)

FLT3 and NPM1 gene mutations in patients with acute myeloid leukemias and the impact of FLT3-ITD mutations on the survival of patients with a normal karyotype
by: Irina Stepanovna Martynkevich, et al.
Published: (2010-12-01)

A Curious Novel Combination of <i>Nucleophosmin</i> (<i>NPM1</i>) Gene Mutations Leading to Aberrant Cytoplasmic Dislocation of <i>NPM1</i> in Acute Myeloid Leukemia (AML)
by: Alessandra Venanzi, et al.
Published: (2021-09-01)

Molecular characterisation of NPM1 and FLT3-ITD mutations in a central South African adult de novo acute myeloid leukaemia cohort
by: Jean F. Kloppers, et al.
Published: (2021-06-01)

<i>FLT3</i>-ITD Allelic Burden and Acute Promyelocytic Leukemia Risk Stratification
by: Andrew Y. Li, et al.
Published: (2021-03-01)

MiR-424 and miR-155 deregulated expression in cytogenetically normal acute myeloid leukaemia: correlation with NPM1 and FLT3 mutation status
by: Faraoni Isabella, et al.
Published: (2012-06-01)

An intensive approach to treatment for older patients with relapsed isolated NPM1 mutated AML
by: Srivasavi Dukka, et al.
Published: (2015-01-01)

Neoantigen-Specific T-Cell Immune Responses: The Paradigm of NPM1-Mutated Acute Myeloid Leukemia
by: Fabio Forghieri, et al.
Published: (2021-08-01)

Absence of BCL-2 Expression Identifies a Subgroup of AML with Distinct Phenotypic, Molecular, and Clinical Characteristics
by: Inke De haes, et al.
Published: (2020-09-01)

Overcoming Resistance to FLT3 Inhibitors in the Treatment of <i>FLT3</i>-Mutated AML
by: Stephen S.Y. Lam, et al.
Published: (2020-02-01)

Outcome of Relapsed or Refractory <i>FLT3</i>-Mutated Acute Myeloid Leukemia Before Second-Generation FLT3 Tyrosine Kinase Inhibitors: A Toulouse–Bordeaux DATAML Registry Study
by: Sarah Bertoli, et al.
Published: (2020-03-01)

High PD-L1 Expression Predicts for Worse Outcome of Leukemia Patients with Concomitant <i>NPM1</i> and <i>FLT3</i> Mutations
by: Barbora Brodská, et al.
Published: (2019-06-01)

The FMS like Tyrosine Kinase 3 (FLT3) Is Overexpressed in a Subgroup of Multiple Myeloma Patients with Inferior Prognosis
by: Normann Steiner, et al.
Published: (2020-08-01)

The assessment of minimal residual disease versus that of somatic mutations for predicting the outcome of acute myeloid leukemia patients
by: Serena Salehzadeh, et al.
Published: (2019-04-01)

Epigenetic Changes in Neoplastic Mast Cells and Potential Impact in Mastocytosis
by: Edyta Reszka, et al.
Published: (2021-03-01)

Comparison of Multiple Clinical Testing Modalities for Assessment of NPM1-Mutant AML
by: Amanda Lopez, et al.
Published: (2021-08-01)

Addition of All-Trans Retinoic Acid to the combination of Fludarabine, Cytarabine, Idarubicin, with or without GCSF in Older Patients with AML Does Not Improve The Outcome in Those with NPM1 Mutations
by: Aziz eNazha, et al.
Published: (2013-09-01)

Bioassay-Guided Isolation of Antiproliferative Compounds from <i>Limbarda crithmoides</i> (L.) Dumort
by: Sabrina Adorisio, et al.
Published: (2020-04-01)

Molecular Detection of Minimal Residual Disease before Allogeneic Stem Cell Transplantation Predicts a High Incidence of Early Relapse in Adult Patients with <i>NPM1</i> Positive Acute Myeloid Leukemia
by: Federico Lussana, et al.
Published: (2019-09-01)

<i>NPM1</i>-Mutated Myeloid Neoplasms with <20% Blasts: A Really Distinct Clinico-Pathologic Entity?
by: Fabio Forghieri, et al.
Published: (2020-11-01)

Novel <i>DNMT3A</i> Germline Variant in a Patient with Multiple Paragangliomas and Papillary Thyroid Carcinoma
by: Sara Mellid, et al.
Published: (2020-11-01)

SPECTRUM AND IMMUNOPHENOTYPIC PROFILE OF ACUTE LEUKEMIA: A TERTIARY CENTER FLOW CYTOMETRY EXPERIENCE
by: Nishit Gupta, et al.
Published: (2019-02-01)

<i>PPARG</i> Hypermethylation as the First Epigenetic Modification in Newly Onset Insulin Resistance in Human Adipocytes
by: Małgorzata Małodobra-Mazur, et al.
Published: (2021-06-01)

Dnmt3aa but Not Dnmt3ab Is Required for Maintenance of Gametogenesis in Nile Tilapia (<i>Oreochromis niloticus</i>)
by: Feilong Wang, et al.
Published: (2021-09-01)

NPM1 and FLT3-(ITD) Gene mutations and laboratory findings in patients with acute myeloid leukemia in Northwest of Iran
by: Sanaat Z, et al.
Published: (2014-10-01)

Emergence of BCR–ABL1 Fusion in AML Post–FLT3 Inhibitor-Based Therapy: A Potentially Targetable Mechanism of Resistance – A Case Series
by: Ahmad S. Alotaibi, et al.
Published: (2020-10-01)

Clinical implications of recurrent gene mutations in acute myeloid leukemia
by: Jifeng Yu, et al.
Published: (2020-03-01)

Pharmacological Inhibition of WIP1 Sensitizes Acute Myeloid Leukemia Cells to the MDM2 Inhibitor Nutlin-3a
by: Maria Chiara Fontana, et al.
Published: (2021-04-01)

Cannot write session to /tmp/vufind_sessions/sess_ate0tr98u873eavgdb310emjf7